Subtopic Deep Dive

← Medicinal Plants and Bioactive Compounds

Clinical Efficacy of Rhodiola Rosea
Research Guide

What is Clinical Efficacy of Rhodiola Rosea?

Clinical Efficacy of Rhodiola Rosea examines randomized controlled trials assessing its effects on depression, anxiety, cognitive impairment, and athletic performance in humans.

Meta-analyses of RCTs show Rhodiola rosea reduces physical and mental fatigue (Ishaque et al., 2012, 112 citations). Open-label trials report improvements in burnout symptoms (Kasper and Dienel, 2017, 27 citations). Over 10 papers from 2012-2024 review its adaptogenic properties in stress and fatigue.

Curated Papers

Key Challenges

Why It Matters

Rhodiola rosea extracts improve burnout symptoms in multicenter trials, supporting integration into mental health protocols (Kasper and Dienel, 2017). Systematic reviews confirm efficacy for physical and mental fatigue, guiding herbal supplement recommendations (Ishaque et al., 2012). Meta-analyses identify responder subgroups for depression phytotherapy, informing personalized medicine (Dobrek and Głowacka, 2023; Tóth-Mészáros et al., 2023).

Key Research Challenges

Heterogeneity in Extract Standardization

RCTs use varying salidroside and rosavin doses, complicating meta-analyses (Ishaque et al., 2012). Standardization lacks uniformity across trials (Panossian and Brendler, 2020). This reduces comparability of efficacy data for fatigue and stress.

Limited Large-Scale RCTs

Most studies are small or open-label, like the burnout trial with exploratory design (Kasper and Dienel, 2017). Few double-blind RCTs exist for depression and athletic performance (Dobrek and Głowacka, 2023). Calls for multicenter trials persist (Tóth-Mészáros et al., 2023).

Identifying Responder Populations

Adaptogenic effects vary by stress level and genetics, per systematic reviews (Panossian and Brendler, 2020). Meta-analyses note subgroup benefits but lack biomarkers (Tóth-Mészáros et al., 2023). Precision targeting remains unresolved.

Essential Papers

Diversity and Antioxidant Activity of Culturable Endophytic Fungi from Alpine Plants of Rhodiola crenulata, R. angusta, and R. sachalinensis

Jin‐Long Cui, Tingting Guo, Zhenxing Ren et al. · 2015 · PLoS ONE · 139 citations

Rhodiola spp. are rare and endangered alpine plants widely used as medicines and food additives by many civilizations since ancient times. Their main effective ingredients (such as salidroside and ...

New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach

Yanfei Liu, Weiliang Weng, Rui Gao et al. · 2019 · Oxidative Medicine and Cellular Longevity · 115 citations

Aging is a progressive disease affecting around 900 million people worldwide, and in recent years, the mechanism of aging and aging-related diseases has been well studied. Treatments for aging-rela...

Rhodiola rosea for physical and mental fatigue: a systematic review

Sana Ishaque, Larissa Shamseer, Cecilia Bukutu et al. · 2012 · BMC Complementary and Alternative Medicine · 112 citations

Depression and Its Phytopharmacotherapy—A Narrative Review

Łukasz Dobrek, Krystyna Głowacka · 2023 · International Journal of Molecular Sciences · 109 citations

Depression is a mental health disorder that develops as a result of complex psycho-neuro-immuno-endocrinological disturbances. This disease presents with mood disturbances, persistent sadness, loss...

Herbal Medicine and Acupuncture for Breast Cancer Palliative Care and Adjuvant Therapy

Guo‐Shiou Liao, Maria Karmella Apaya, Lie‐Fen Shyur · 2013 · Evidence-based Complementary and Alternative Medicine · 73 citations

Breast cancer is a life-threatening disease among women worldwide with annual rates of reported incidence and death increasing alarmingly. Chemotherapy is a recommended and effective treatment opti...

The Role of Adaptogens in Prophylaxis and Treatment of Viral Respiratory Infections

Alexander Panossian, Thomas Brendler · 2020 · Pharmaceuticals · 61 citations

The aim of our review is to demonstrate the potential of herbal preparations, specifically adaptogens for prevention and treatment of respiratory infections, as well as convalescence, specifically ...

Effect of Traditional Chinese Medicine on the Cardiovascular Diseases

Yang Jiang, Qi Zhao, Lin Li et al. · 2022 · Frontiers in Pharmacology · 34 citations

Background: Traditional Chinese medicine (TCM) is the health care system developed with the help of clinical trials that are based ideally on the scientific model of regulation. Objective: This sys...

Reading Guide

Foundational Papers

Start with Ishaque et al. (2012, 112 citations) for systematic review of fatigue RCTs, then Liao et al. (2013, 73 citations) for adjunctive use context.

Recent Advances

Kasper and Dienel (2017) for burnout trial; Tóth-Mészáros et al. (2023) for stress meta-analysis; Panossian et al. (2024) for hybrid preparations.

Core Methods

RCTs with fatigue scales (e.g., MFI), burnout inventories (MBI), meta-analyses via random-effects models, GRADE for evidence quality.

How PapersFlow Helps You Research Clinical Efficacy of Rhodiola Rosea

Discover & Search

Research Agent uses searchPapers('Rhodiola rosea RCT fatigue') to find Ishaque et al. (2012), then citationGraph to map 112 citing papers on adaptogens, and findSimilarPapers for meta-analyses like Tóth-Mészáros et al. (2023). exaSearch uncovers unpublished trials on burnout responders.

Analyze & Verify

Analysis Agent applies readPaperContent on Kasper and Dienel (2017) to extract efficacy metrics, verifyResponse with CoVe against Ishaque et al. (2012) for GRADE grading of moderate evidence on fatigue, and runPythonAnalysis to meta-analyze effect sizes from RCTs using pandas for forest plots.

Synthesize & Write

Synthesis Agent detects gaps in responder stratification from Dobrek and Głowacka (2023), flags contradictions in extract standardization, then Writing Agent uses latexEditText for RCT summary tables, latexSyncCitations for 10+ references, and latexCompile for a review manuscript with exportMermaid diagrams of trial flows.

Use Cases

"Run meta-analysis on Rhodiola rosea RCTs for depression effect sizes."

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis with forest plot) → researcher gets CSV of pooled ORs and GRADE scores.

"Draft LaTeX review of Rhodiola rosea burnout trials."

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Kasper 2017, Ishaque 2012) + latexCompile → researcher gets compiled PDF with citations and tables.

"Find code for Rhodiola bioactive modeling from papers."

Research Agent → paperExtractUrls (Cui et al. 2015) → paperFindGithubRepo → githubRepoInspect → researcher gets antioxidant simulation scripts linked to endophytic fungi data.

Automated Workflows

Deep Research workflow runs systematic review: searchPapers(50+ Rhodiola RCTs) → citationGraph → DeepScan(7-step GRADE analysis) → structured report on efficacy. Theorizer generates hypotheses on responder biomarkers from Ishaque (2012) and Tóth-Mészáros (2023) via contradiction flagging. DeepScan verifies meta-analysis claims with CoVe checkpoints on Panossian (2020).

Try Doxa for Clinical Efficacy of Rhodiola Rosea Research

Frequently Asked Questions

What defines clinical efficacy studies of Rhodiola rosea?

RCTs and meta-analyses measuring outcomes in fatigue, burnout, depression, and performance using standardized extracts (Ishaque et al., 2012).

What methods assess Rhodiola rosea efficacy?

Systematic reviews and meta-analyses of RCTs, open-label trials, with outcomes like fatigue scales and burnout inventories (Ishaque et al., 2012; Kasper and Dienel, 2017; Tóth-Mészáros et al., 2023).

What are key papers on Rhodiola rosea?

Ishaque et al. (2012, 112 citations) on fatigue; Kasper and Dienel (2017, 27 citations) on burnout; Tóth-Mészáros et al. (2023) meta-analysis on stress.

What open problems exist in Rhodiola rosea research?

Standardized extracts in large RCTs, biomarker-defined responders, long-term safety in depression (Dobrek and Głowacka, 2023; Panossian and Brendler, 2020).